Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Corticotropin releasing factor receptor 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | Get druggable targets OG5_130760 | All targets in OG5_130760 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | Get druggable targets OG5_130760 | All targets in OG5_130760 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | Get druggable targets OG5_130760 | All targets in OG5_130760 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_130760 | All targets in OG5_130760 |
Schistosoma japonicum | IPR001879,Hormone receptor, extracellular,domain-containing | Get druggable targets OG5_130760 | All targets in OG5_130760 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Onchocerca volvulus | Pseudouridine-5 prime-monophosphatase homolog | Corticotropin releasing factor receptor 1 | 415 aa | 401 aa | 27.2 % |
Onchocerca volvulus | Corticotropin releasing factor receptor 1 | 415 aa | 401 aa | 30.2 % | |
Loa Loa (eye worm) | pigment dispersing factor receptor c | Corticotropin releasing factor receptor 1 | 415 aa | 394 aa | 27.7 % |
Loa Loa (eye worm) | hypothetical protein | Corticotropin releasing factor receptor 1 | 415 aa | 359 aa | 21.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.5395 | 0.2969 | 0.5 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.5395 | 0.2969 | 0.5 |
Trypanosoma cruzi | metacaspase 5, putative | 0.5395 | 0.2969 | 0.5 |
Brugia malayi | Cell death protein 3 precursor | 0.7117 | 0.4257 | 1 |
Brugia malayi | mucosa associated lymphoid tissue lymphoma translocation protein 1 | 0.5395 | 0.2969 | 0.6975 |
Schistosoma mansoni | subfamily C14A unassigned peptidase (C14 family) | 0.5395 | 0.2969 | 0.2969 |
Leishmania major | metacaspase, putative | 0.5395 | 0.2969 | 0.5 |
Plasmodium vivax | metacaspase 1, putative | 0.5395 | 0.2969 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.5395 | 0.2969 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.5395 | 0.2969 | 0.5 |
Echinococcus multilocularis | caspase 3, apoptosis cysteine peptidase | 1.4799 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.5395 | 0.2969 | 0.6975 |
Echinococcus multilocularis | caspase | 1.4799 | 1 | 1 |
Echinococcus granulosus | caspase 2 | 0.7117 | 0.4257 | 0.4257 |
Loa Loa (eye worm) | hypothetical protein | 0.7117 | 0.4257 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.5395 | 0.2969 | 0.5 |
Trypanosoma brucei | metacaspase 5, putative | 0.5395 | 0.2969 | 0.5 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.5395 | 0.2969 | 0.5 |
Schistosoma mansoni | caspase-7 (C14 family) | 1.4799 | 1 | 1 |
Trypanosoma cruzi | metacaspase, putative | 0.5395 | 0.2969 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.5395 | 0.2969 | 0.5 |
Plasmodium falciparum | metacaspase-like protein | 0.5395 | 0.2969 | 0.5 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.7117 | 0.4257 | 0.4257 |
Schistosoma mansoni | caspase-3 (C14 family) | 1.4799 | 1 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.5395 | 0.2969 | 0.5 |
Trypanosoma brucei | metacaspase | 0.5395 | 0.2969 | 0.5 |
Echinococcus granulosus | caspase 8 | 0.5395 | 0.2969 | 0.2969 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.5395 | 0.2969 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.5395 | 0.2969 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.5395 | 0.2969 | 0.5 |
Echinococcus multilocularis | caspase 8 | 0.5395 | 0.2969 | 0.2969 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.5395 | 0.2969 | 0.5 |
Trypanosoma cruzi | metacaspase, putative | 0.5395 | 0.2969 | 0.5 |
Trypanosoma cruzi | metacaspase 5, putative | 0.5395 | 0.2969 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.5395 | 0.2969 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.5395 | 0.2969 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.5395 | 0.2969 | 0.5 |
Onchocerca volvulus | Cell death protein 3 homolog | 0.7117 | 0.4257 | 1 |
Echinococcus granulosus | caspase | 1.4799 | 1 | 1 |
Echinococcus multilocularis | caspase 3 | 0.9404 | 0.5967 | 0.5967 |
Trypanosoma brucei | Metacaspase-4 | 0.5395 | 0.2969 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.5395 | 0.2969 | 0.5 |
Trypanosoma brucei | metacaspase MCA3 | 0.5395 | 0.2969 | 0.5 |
Plasmodium falciparum | metacaspase 1 | 0.5395 | 0.2969 | 0.5 |
Trypanosoma cruzi | metacaspase, putative | 0.5395 | 0.2969 | 0.5 |
Trypanosoma brucei | metacaspase MCA2 | 0.5395 | 0.2969 | 0.5 |
Echinococcus multilocularis | caspase 2 | 0.7117 | 0.4257 | 0.4257 |
Trichomonas vaginalis | conserved hypothetical protein | 0.5395 | 0.2969 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.5395 | 0.2969 | 0.5 |
Trypanosoma cruzi | metacaspase, putative | 0.5395 | 0.2969 | 0.5 |
Echinococcus granulosus | caspase 3 | 0.9404 | 0.5967 | 0.5967 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.5395 | 0.2969 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 2.2 nM | Displacement of [125I]Tyr-o-CRF from CRF1 receptor in rat frontal cortex homogenates | ChEMBL. | 17402721 |
IC50 (binding) | = 2.2 nM | Displacement of [125I]Tyr-o-CRF from CRF1 receptor in rat frontal cortex homogenates | ChEMBL. | 17402721 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.